ANCA-associated vasculitis: open trials in Germany

8 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

2024-519592-26-00
Treatment of patients with autoantibody-positive autoimmune diseases and severe interstitial lung fibrosis with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector - a single center Phase I/II clinical trial (HD-CAR-ILD-1)
Trial Treatment · Phase 1 · Universitaetsklinikum Heidelberg AöR
Universitaetsklinikum Heidelberg AöR, Heidelberg
Registry updated 2026-09-01
2024-519491-60-00
An open-label phase I/II, single-center, interventional singlearm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases
Trial Treatment · Phase 1/2 · Universitaetsklinikum Tuebingen AöR
Universitaetsklinikum Tuebingen AöR, Tuebingen
Registry updated 2026-08-14
NCT06047171
Rescue of Nephrons With ALE.F02 (RENAL-F02)
Trial Treatment · Phase 2 · Alentis Therapeutics AG
Charité - Universitaetsmedizin Berlin, Berlin · Universitaetsklinikum Koeln (AoeR), Cologne · Universitaetsklinikum Carl Gustav Carus Dresden, Dresden · Universitaetsklinikum - Essen, Essen · Medizinische Hochschule Hannover (MHH), Hanover · Universitaetsklinikum Leipzig, Leipzig · Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck · Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München
Registry updated 2026-08-14
2023-508398-10-00
Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
Trial Treatment · Phase 4 · Region Oestergoetland
Article 11 CTR DE, DO NOT EDIT
Registry updated 2026-07-08
2025-522853-21-01
An open label, phase I/II study investigating the safety and efficacy of a CD3/CD20 bispecific T-cell engager therapy in patients with active, treatment refractory, ANCA-IgG-positive associated vasculitis. The RENEWAL study
Trial Treatment · Phase 1/2 · Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
Fraunhofer Institute For Translational Medicine And Pharmacology ITMP, Berlin
Registry updated 2026-01-30
NCT07150000
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Research · University of Bonn
University Hospital Bonn, Bonn
Registry updated 2025-09-02
NCT06696027
AYLo - AutoimmunitY and Loss of y
Research · University of Bonn
Department of Rheumatology, Bonn
Registry updated 2025-04-10
NCT06590545
Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
Trial Treatment · Phase 1/2 · David Simon
Charite Universitaetsmedizin Berlin KöR, Berlin
Registry updated 2024-09-19

All ANCA-associated vasculitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error